InsidersTradesSigma
Track the 이엔셀 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 이엔셀 has recorded 5 insider filings. Market capitalisation: €55.8bn. The latest transaction was disclosed on 2 April 2026 (Sale). Among the most active insiders: 장종욱. The full history is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€41,965
2 ops.
Buy Volume
€1m
2 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,867 of 29,063 companies
6.2
score / 100
Value8
Quality4
FCF yld-24%
Earn yld-29%
EV/EBITDA·
ROE-42%
Gross mgn-46%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 2 April 2026
Declarations5 total
5 of 5 declarations
Acerca de 이엔셀
이엔셀 es una empresa farmacéutica y de atención médica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el sector médico.